Wolfgang Buechele - Merck KGaA Chairman of the Supervisory Board
| MKKGY Stock | USD 31.09 0.02 0.06% |
Chairman
Dr. Wolfgang Buechele is Chairman of the Supervisory Board at Merck KGaA since May 9, 2014. He was member of Supervisory Board from July 1, 2009 to May 9, 2014. He is Chief Executive Officer of BorsodChem Zrt. He was Member of the Board of Partners of E. Merck KG since July 1, 2009. He is Member of the Board of Kemira Oij. He is Member of the Finance Committee at the Company. since 2014.
| Age | 58 |
| Tenure | 10 years |
| Professional Marks | Ph.D |
| Phone | 49 6151 72 0 |
| Web | https://www.merckgroup.com |
Merck KGaA Management Efficiency
The company has return on total asset (ROA) of 0.0656 % which means that it generated a profit of $0.0656 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1422 %, meaning that it generated $0.1422 on every $100 dollars invested by stockholders. Merck KGaA's management efficiency ratios could be used to measure how well Merck KGaA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | CHAIRMAN Age | ||
| Daniel Herndon | Home Federal Bancorp | 77 | |
| Luis Orozco | Betterware De Mexico | 71 | |
| David Mott | Mersana Therapeutics | 52 | |
Management Performance
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0656 |
Merck KGaA ADR Leadership Team
Elected by the shareholders, the Merck KGaA's board of directors comprises two types of representatives: Merck KGaA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merck. The board's role is to monitor Merck KGaA's management team and ensure that shareholders' interests are well served. Merck KGaA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merck KGaA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Matthias Heinzel, CEO Board | ||
| Gerhard Schmitz, Head Accounting | ||
| Stefan Oschmann, Chairman of Executive Board and CEO | ||
| Constantin Fest, Head of Investor Relations | ||
| Michaela Glenck, Member of the Supervisory Board | ||
| Veit Ulshoefer, Member of the Supervisory Board, Employee Representative | ||
| Gabriele Eismann, Member of the Supervisory Board, Employee Representative | ||
| Peter Guenter, CEO Board | ||
| Wolfgang Buechele, Chairman of the Supervisory Board | ||
| Barbara Weiland, Chief Officer | ||
| Belen MD, Chair CEO | ||
| Anke Schenkel, Head of Group Controlling & Risk Management | ||
| Marcus Kuhnert, Member of the Executive Board, CFO | ||
| Siegfried Karjetta, Member of the Supervisory Board | ||
| Alexander Putz, Member of the Supervisory Board, Employee Representative | ||
| Friederike Rotsch, Group Compliance | ||
| Dietmar Oeter, Member of the Supervisory Board, Employee Representative | ||
| Dirk Toepfer, Chief Officer | ||
| Gregor Schulz, Member of the Supervisory Board | ||
| Theo Siegert, Member of the Supervisory Board | ||
| Constantin Birnstiel, Head of Group Communications | ||
| Edeltraud Glaenzer, Member of the Supervisory Board, Employee Representative | ||
| Kai Beckmann, Chief Administrative Officer, Member of the Executive Board | ||
| Helga RuebsamenSchaeff, Member of the Supervisory Board | ||
| Udit Batra, CEO Life Science, Member of the Executive Board | ||
| Michael Fletterich, Vice Chairman of the Supervisory Board, Employee Representative | ||
| Crocifissa Attardo, Member of the Supervisory Board, Employee Representative | ||
| Albrecht Merck, Member of the Supervisory Board | ||
| Mechthild Auge, Member of the Supervisory Board, Employee Representative | ||
| Belen Garijo, CEO Healthcare, Member of the Executive Board | ||
| Walter Galinat, CEO Performance Materials, Member of the Executive Board | ||
| Tobias Thelen, Member of the Supervisory Board | ||
| Isabel Paoli, Chief Strategy Officer, Head of Communications |
Merck Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Merck KGaA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0656 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 92.22 B | |||
| Shares Outstanding | 2.17 B | |||
| Shares Owned By Institutions | 0.03 % | |||
| Price To Earning | 33.17 X | |||
| Price To Book | 2.75 X | |||
| Price To Sales | 3.86 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Merck KGaA in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Merck KGaA's short interest history, or implied volatility extrapolated from Merck KGaA options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck KGaA ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Merck KGaA ADR information on this page should be used as a complementary analysis to other Merck KGaA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Merck Pink Sheet analysis
When running Merck KGaA's price analysis, check to measure Merck KGaA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck KGaA is operating at the current time. Most of Merck KGaA's value examination focuses on studying past and present price action to predict the probability of Merck KGaA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck KGaA's price. Additionally, you may evaluate how the addition of Merck KGaA to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| CEOs Directory Screen CEOs from public companies around the world |